CJC-DAC 5 MG
CJC-DAC 5mg is supplied strictly as a laboratory research peptide for analytical and scientific use only. Available to qualified researchers, laboratories, and institutions in Perth and across Western Australia, with Australian-based fulfilment.
Intended for in-vitro research, assay development, method validation, and controlled scientific investigation conducted by appropriately qualified professionals.
Product details
-
Product: CJC-1295 with DAC
- Molecular Formula: C152H252N44O42
-
Strength / size: 5 mg
-
Category: Research peptide / laboratory compound
-
Use: Laboratory research only
-
Certification: Certificate of Analysis (COA) / batch documentation (where available)
-
Supply: Perth & Western Australia (AU shipping)
SEQUENCE: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Mal)-NH2
CJC-1295 DAC is a synthetic analog of growth hormone-releasing hormone (GHRH) that has the potential to enhance plasma levels of growth hormone (GH) and insulin-like growth factor 1 (IGF-1). Drug affinity complex (DAC) is an additive component that is considered to prolong the half-life of CJC-1295. Researchers have created several synthetic modifications of growth hormone-releasing hormone (GHRH), which appear to retain certain selective traits of the hormone while eliminating others. CJC-1295 is one such synthetic analog, comprising the first 29 amino acids of GHRH. This is believed to lend secretagogue characteristics with greater solubility, which may be easier to synthesize in larger volumes.
